FN1 and melanoma: The results demonstrated that the antibody markedly reduced the adhesion of these cells to sVEGFR-1-containing ECM, whereas it did not affect melanoma adhesion to fibronectin (Figure 4A for WM266-4 and Figure 5A for HUV-ST cells).